Protein Kinase A As a Promising Target for Heart Failure Drug Development

Overview

Journal Arch Med Res

Specialty General Medicine

Date 2019 Jan 16

PMID 30642654

Citations 20

Authors

Nancy S Saad

Mohammad T Elnakish

Amany A E Ahmed

Paul M L Janssen

Affiliations

Soon will be listed here.

Abstract

Heart failure (HF) is a clinical syndrome characterized by impaired ability of the heart to fill or eject blood. HF is rather prevalent and it represents the foremost reason of hospitalization in the United States. The costs linked to HF overrun those of all other causes of disabilities, and death in the United States and all over the developed as well as the developing countries which amplify the supreme significance of its prevention. Protein kinase (PK) A plays multiple roles in heart functions including, contraction, metabolism, ion fluxes, and gene transcription. Altered PKA activity is likely to cause the progression to cardiomyopathy and HF. Thus, this review is intended to focus on the roles of PKA and PKA-mediated signal transduction in the healthy heart as well as during the development of HF. Furthermore, the impact of cardiac PKA inhibition/activation will be highlighted to identify PKA as a potential target for the HF drug development.

Citing Articles

Modulation of cAMP/cGMP signaling as prevention of congenital heart defects in Pde2A deficient embryos: a matter of oxidative stress.

Cardarelli S, Biglietto M, Orsini T, Fustaino V, Monaco L, do Rego A Cell Death Dis. 2024; 15(2):169.

PMID: 38395995 PMC: 10891154. DOI: 10.1038/s41419-024-06549-1.

Altering Calcium Sensitivity in Heart Failure: A Crossroads of Disease Etiology and Therapeutic Innovation.

Saad N, Mashali M, Repas S, Janssen P Int J Mol Sci. 2023; 24(24).

PMID: 38139404 PMC: 10744146. DOI: 10.3390/ijms242417577.

Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?.

Lymperopoulos A Expert Rev Clin Pharmacol. 2023; 16(7):623-630.

PMID: 37403791 PMC: 10529896. DOI: 10.1080/17512433.2023.2233891.

Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy.

Luciani M, Montalbano M, Troncone L, Bacchin C, Uchida K, Daniele G Eur Heart J. 2023; 44(17):1560-1570.

PMID: 37122097 PMC: 10324644. DOI: 10.1093/eurheartj/ehad205.

Tectorigenin targets PKACα to promote GLUT4 expression in skeletal muscle and improve insulin resistance and .

Yao X, Liu L, Shao W, Bai M, Ding X, Wang G Int J Biol Sci. 2023; 19(5):1579-1596.

PMID: 37056927 PMC: 10086741. DOI: 10.7150/ijbs.80125.

References

Mathiyalagan P, Chang L, Du X, El-Osta A . Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle. 2010; 9(3):612-7. DOI: 10.4161/cc.9.3.10612. View

Saad N, Elnakish M, Brundage E, Biesiadecki B, Kilic A, Ahmed A . Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium. Life Sci. 2018; 215:119-127. PMC: 6279240. DOI: 10.1016/j.lfs.2018.10.065. View

Wang Z, Fermini B, Nattel S . Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993; 73(2):276-85. DOI: 10.1161/01.res.73.2.276. View

Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K . Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 1995; 26(6):1424-31. DOI: 10.1016/0735-1097(95)00338-X. View

Shah A, Spurgeon H, Sollott S, Talo A, Lakatta E . 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res. 1994; 74(5):970-8. DOI: 10.1161/01.res.74.5.970. View

Yamagishi S, Edelstein D, Du X, Kaneda Y, Guzman M, Brownlee M . Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem. 2001; 276(27):25096-100. DOI: 10.1074/jbc.M007383200. View

Enns L, Bible K, Emond M, Ladiges W . Mice lacking the Cβ subunit of PKA are resistant to angiotensin II-induced cardiac hypertrophy and dysfunction. BMC Res Notes. 2010; 3:307. PMC: 2993729. DOI: 10.1186/1756-0500-3-307. View

Chang S, McKinsey T, Zhang C, Richardson J, Hill J, Olson E . Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol. 2004; 24(19):8467-76. PMC: 516756. DOI: 10.1128/MCB.24.19.8467-8476.2004. View

Antos C, Frey N, Marx S, Reiken S, Gaburjakova M, Richardson J . Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res. 2001; 89(11):997-1004. DOI: 10.1161/hh2301.100003. View

10.

Robinet A, Hoizey G, Millart H . PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning. Cardiovasc Res. 2005; 66(3):530-42. DOI: 10.1016/j.cardiores.2005.02.010. View

11.

Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J . Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res. 1994; 75(3):434-42. DOI: 10.1161/01.res.75.3.434. View

12.

Murray P, Baig H, Fishbein M, Vatner S . Effects of exerimental right ventricular hypertrophy on myocardial blood flow in conscious dogs. J Clin Invest. 1979; 64(2):421-7. PMC: 372135. DOI: 10.1172/JCI109478. View

13.

Dash R, Kadambi V, Schmidt A, Tepe N, Biniakiewicz D, Gerst M . Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation. 2001; 103(6):889-96. DOI: 10.1161/01.cir.103.6.889. View

14.

Mattiazzi A, Hove-Madsen L, Bers D . Protein kinase inhibitors reduce SR Ca transport in permeabilized cardiac myocytes. Am J Physiol. 1994; 267(2 Pt 2):H812-20. DOI: 10.1152/ajpheart.1994.267.2.H812. View

15.

Mery P, Pavoine C, Belhassen L, Pecker F, Fischmeister R . Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem. 1993; 268(35):26286-95. View

16.

Meinkoth J, Alberts A, Went W, Fantozzi D, Taylor S, Hagiwara M . Signal transduction through the cAMP-dependent protein kinase. Mol Cell Biochem. 1993; 127-128:179-86. DOI: 10.1007/BF01076769. View

17.

Yamazaki T, Komuro I, Zou Y, Kudoh S, Shiojima I, Hiroi Y . Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors. Circulation. 1997; 95(5):1260-8. DOI: 10.1161/01.cir.95.5.1260. View

18.

Fontes-Sousa A, Pires A, Carneiro C, Bras-Silva C, Leite-Moreira A . Effects of adrenomedullin on systolic and diastolic myocardial function. Peptides. 2009; 30(4):796-802. DOI: 10.1016/j.peptides.2008.12.011. View

19.

Proud C, Rylatt D, Yeaman S, Cohen P . Amino acid sequences at the two sites on glycogen synthetase phosphorylated by cyclic AMP-dependent protein kinase and their dephosphorylation by protein phosphatase-III. FEBS Lett. 1977; 80(2):435-42. DOI: 10.1016/0014-5793(77)80493-6. View

20.

Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K . Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest. 1994; 94(5):2158-61. PMC: 294670. DOI: 10.1172/JCI117573. View